CN Patent

CN111116468A — 用于治疗胰腺癌的喹啉类化合物或其药学上可接受的盐

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2020-05-08 · 6y expired

What this patent protects

本发明提供了一种用于治疗胰腺癌的式(I)所示的喹啉衍生物，及其在制备用于肿瘤治疗的药物组合物的用途，式(I)所示的喹啉衍生物结构式如下：

USPTO Abstract

本发明提供了一种用于治疗胰腺癌的式(I)所示的喹啉衍生物，及其在制备用于肿瘤治疗的药物组合物的用途，式(I)所示的喹啉衍生物结构式如下：

Drugs covered by this patent

Patent Metadata

Patent number
CN111116468A
Jurisdiction
CN
Classification
—
Expires
2020-05-08
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.